Research advances in role of carvedilol in management of cirrhotic portal hypertension: a review of clinical trials
The primary aim of preventing variceal bleeding in liver cirrhosis is to reduce portosystemic pressure gradient. Carvedilol is a non-selective beta blocker with selective inhibition of α-1 receptor and blockage of calcium channel. This paper reviews the role of carvedilol in reducing hepatic venous...
| Main Author: | |
|---|---|
| Format: | Article |
| Language: | zho |
| Published: |
Editorial Department of Journal of Clinical Hepatology
2015-03-01
|
| Series: | Linchuang Gandanbing Zazhi |
| Subjects: | |
| Online Access: | http://www.lcgdbzz.org/qk_content.asp?id=6388&ClassID=213155719 |